Welcome to our dedicated page for SiriusPoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SiriusPoint Ltd. SEC filings document the regulatory record of a global specialty insurance and reinsurance underwriter. Its 8-K filings report operating results, financial supplements, investor presentations, business-structure changes, executive transitions, and other material events. Regulation FD exhibits provide additional detail on underwriting performance, services income, investment results, capital management, and risk-based capital measures.
The company’s proxy materials describe board elections, director independence, committee assignments, executive compensation, shareholder voting matters, and governance practices. Filings also disclose SiriusPoint’s capital structure, including common stock and preference-share matters, and include records such as Form 25 for the removal from listing and registration of its 8.00% Resettable Fixed Rate Preference Shares, Series B.
SiriusPoint Ltd. reported higher profitability for the first half of 2026, with net income of $170.8 million and net income available to common shareholders of $168.2 million, compared with $125.3 million and $116.8 million a year earlier. Diluted EPS was $1.40 for the six‑month period.
Total revenues were $1,518.7 million, while the core underwriting combined ratio improved to 90.1% from 92.4%, helped by catastrophe losses of $6.7 million versus $67.4 million in 2025 and $32.9 million of favorable prior‑year reserve development. Net investment income was $131.9 million, slightly below $139.4 million last year.
Total assets were $12,651.7 million and total shareholders’ equity attributable to SiriusPoint shareholders was $2,275.9 million as of June 30, 2026, down from $2,469.8 million at year‑end, reflecting $83.2 million of other comprehensive loss driven largely by unrealized losses on available‑for‑sale debt securities and capital returns.
The company completed the $140.4 million sale of its 49% stake in Arcadian Risk Capital, recognizing a $25.2 million gain, acquired Assist America for $44.0 million (recording $18.6 million of goodwill), redeemed $200.0 million of Series B preference shares, and repurchased $73.3 million of common shares. It also agreed to acquire the World Nomads travel insurance business for approximately $47 million, with closings expected in the second half of 2026 and 2027.
SiriusPoint Ltd. reported strong results for the quarter and six months ended June 30, 2026. For the second quarter, net income available to common shareholders was $68.6 million, or $0.58 per diluted share, and operating earnings per share were $0.67. Annualized return on equity was 12.0%, with operating ROE of 13.8%. The consolidated combined ratio was 88.5%, and the Core combined ratio was 91.4%.
For the first half of 2026, net income available to common shareholders rose to $168.2 million, up 44% versus the prior year, with diluted EPS of $1.40 and operating EPS of $1.37, up 17%. The Core combined ratio improved to 90.1%, reflecting materially lower catastrophe losses of $6.7 million compared with $67.4 million a year earlier. Book value per diluted common share excluding AOCI increased 8% since December 31, 2025 to $19.48, supported by underwriting profitability and a BSCR capital ratio of 239%. Year to date, SiriusPoint repurchased $95 million of common shares, contributing to $295 million of total capital returned in 2026.
SiriusPoint Ltd Chief Financial Officer James J. McKinney reported a routine tax-related share disposition. On May 31, 2026, 3,648 Common Shares were withheld at $21.35 per share to cover current tax liabilities tied to vesting of restricted share units. This was not an open-market sale. After the withholding, McKinney directly holds 50,711 Common Shares, which the disclosure notes includes restricted shares.
Robart Jason reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Jason Robart reported an equity grant of 5,903 Common Shares at $23.29 per share. This is a compensation-related award, not an open-market purchase. Following the grant, he holds 97,303 Common Shares directly.
The holding total includes restricted shares that are scheduled to vest in full on May 30, 2027, subject to his continued service as a director. This filing reflects routine director compensation and does not indicate discretionary buying or selling in the market.
Mahmud Mehdi reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Mahmud Mehdi received a grant of 5,903 Common Shares at a reference price of $23.29 per share. This award increases his direct holdings to 123,558 Common Shares.
The position includes restricted shares scheduled to vest in full on May 30, 2027, conditional on his continued service as a director.
Masojada Bronislaw Edmund reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Bronislaw Edmund Masojada received an equity award of 5,903 Common Shares, valued at $23.29 per share. This was a grant, not an open-market purchase, and increased his direct holdings to 65,727 Common Shares. The position includes restricted shares that vest in full on May 30, 2027, subject to his continued service as a director.
Ludlow Sharon M reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Sharon M. Ludlow reported receiving a grant of 5,903 Common Shares of the company on May 29, 2026, recorded at $23.29 per share. This is a compensation-related award, not an open‑market purchase.
After this grant, Ludlow directly holds 160,693 Common Shares, which include restricted shares. The footnotes state that some of these restricted shares will vest in full on May 30, 2027, if she continues to serve as a director through that date.
Hudson Martin Peter reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Hudson Martin Peter received an equity award of 5,903 Common Shares at $23.29 per share. This grant increases his direct holdings to 9,601 Common Shares. The total includes restricted shares scheduled to vest in full on May 30, 2027, contingent on his continued service as a director.
SiriusPoint Ltd director Susan Lee Cross reported an equity award of 5,903 Common Shares on May 29, 2026. The shares were valued at $23.29 per share at grant and represent a compensation-related acquisition, not an open-market purchase.
After this grant, Cross directly holds 23,887 Common Shares, which include restricted shares. A portion of these restricted shares will vest in full on May 30, 2027, subject to her continued service as a director.
Purtill Sabra R. reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Sabra R. Purtill received a grant of 5,903 common shares as equity compensation. The shares are restricted and vest in full on May 30, 2027, subject to her continued service as a director. Following this award, she directly holds 5,903 common shares.